Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Department of Advanced Pediatric Medicine, Tohoku University School of Medicine, Tokyo 157-8535, Japan.
Endocr J. 2019 Apr 25;66(4):387-393. doi: 10.1507/endocrj.EJ18-0494. Epub 2019 Feb 19.
Endogenous and exogenous androgens induce masculinization of external genitalia through binding to the androgen receptor (AR). The target genes of androgens in external genitalia remain to be determined, although previous studies have shown that the apolipoprotein D gene (APOD) was significantly upregulated by dihydrotestosterone (DHT), the most potent androgen in humans. In the present study, we performed microarray analysis for genital skin fibroblasts obtained from four boys with buried penis (the control individuals) and a patient with partial androgen insensitivity syndrome (PAIS) due to a hypomorphic mutation in AR (the PAIS patient). We identified 24 transcripts that were upregulated or downregulated by DHT in all samples of control individuals and, to a lesser extent, in the sample of the PAIS patient. Differences between DHT-treated and -untreated samples were small; the results of 24 transcripts did not reach statistical significance. The 24 transcripts included CYP1B1, a gene possibly involved in the development of genital tubercle in mice, and APOD, as well as several genes that have been reported as androgen targets in prostate or other tissues. The results of this study indicate that androgen-mediated masculinization of external genitalia is unlikely to depend on massive transcriptional changes in specific AR target genes. Rather, minor transcriptional changes of several genes, and/or a complex molecular network may play a major role in penile development. Importantly, our data suggest the possible involvement of CYP1B1 in human genital development and confirm the clinical importance of APOD as a biomarker for AR function.
内源性和外源性雄激素通过与雄激素受体(AR)结合诱导外生殖器的男性化。尽管先前的研究表明载脂蛋白 D 基因(APOD)被二氢睾酮(DHT)显著上调,DHT 是人类最有效的雄激素,但外生殖器中雄激素的靶基因仍有待确定。在本研究中,我们对来自四个患有埋藏阴茎的男孩(对照组)和一个由于 AR 低功能突变导致部分雄激素不敏感综合征(PAIS)的患者的生殖器皮肤成纤维细胞进行了微阵列分析。我们鉴定了 24 个在所有对照组样本中以及在 PAIS 患者样本中较少程度上调或下调的转录本。DHT 处理和未处理样本之间的差异较小;24 个转录本的结果未达到统计学意义。这 24 个转录本包括 CYP1B1,一种可能参与小鼠生殖器芽发育的基因,以及 APOD,以及一些已在前列腺或其他组织中被报道为雄激素靶标的基因。本研究的结果表明,外生殖器的雄激素介导的男性化不太可能依赖于特定 AR 靶基因的大量转录变化。相反,几个基因的微小转录变化和/或复杂的分子网络可能在外生殖器发育中起主要作用。重要的是,我们的数据表明 CYP1B1 可能参与人类生殖器发育,并证实了 APOD 作为 AR 功能生物标志物的临床重要性。